It’s been 19 years now, yet every morning I wake up, feel the tingling and wonder, maybe just for a few seconds.
The value of monitoring a chronic disease
Metastatic breast cancer is now considered a chronic condition with effective treatments that in many ways allow women to lead a normal or near normal life. Yet, many women live with the fear that their cancer may no longer be responding to medication or the disease has flared in advance of overt clinical symptoms. We believe that a simple blood test can effectively monitor medication and help detect recurrences of HER2 tumors. Plus, monitoring helps to reduce anxiety. Therein lies the value of monitoring serum HER2 for women with metastatic HER2 tumors--the possibility of real-time, actionable information and additional peace of mind.
About Martell Diagnostic
Martell Diagnostic Laboratories
Business model: reference laboratory
Location: Roseville, MN
Target Oncology Marketing Agreement
(October 2016) We engaged a national network of oncology sales representatives.
Welcome Jessica McDougall
(July 2016) Jessica will be running our ELISA tests under the supervision of our Laboratory Manager and pathologist Laboratory Director.
New Evidence Supports Serum HER2 Monitoring
(March 2016) See a recent article published in the Journal of Clinical Oncology (Lee CK, et al, March 2016.)
New Office and Lab Space
We have moved and are now located in Roseville, MN. This suburb of St. Paul is home to much of the large Minnesota medical device industry.
Woman's Hospital Enters Service Agreement
(February 2014) Woman's Hospital was an original beta site for the sHER2/neu test kit and is the largest breast cancer program in Baton Rouge, LA.